Literature DB >> 29270811

Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy.

Nanami Nomi1, Manami Ota2, Miho Fukumura1, Yoshihisa Nuno1, Makoto Hatano3, Makiko Wakuta4, Ryoji Yanai5, Kazuhiro Kimura3.   

Abstract

PURPOSE: To report 2 cases of paclitaxel-related maculopathy manifesting as cystoid macular edema (CME) with late petaloid hyperfluorescence on indocyanine green angiography (IA). CASES: A 74-year-old man (patient 1) undergoing paclitaxel chemotherapy for gastric and metastatic liver cancer and a 69-year-old man (patient 2) receiving paclitaxel for hypopharyngeal cancer presented with anorthopia in both eyes. Spectral domain-optical coherence tomography (SD-OCT) revealed macular edema in both eyes of each patient. Fluorescein angiography showed weak petaloid pooling around the fovea in the late phase. IA revealed CME with petaloid hyperfluorescence that matched the region of macular edema detected by SD-OCT. The CME was attenuated in the right eye but not in the left eye of patient 1 at 2 weeks after discontinuation of paclitaxel treatment, whereas it was no longer apparent in either eye at 3 months. The CME was no longer detected in either eye of patient 2 at 3 months after discontinuation of paclitaxel.
CONCLUSION: These cases suggest that paclitaxel-induced CME may result from intraretinal accumulation of intracellular fluid and minimal impairment of the blood retinal barrier.

Entities:  

Keywords:  Cystoid macular edema; Indocyanine green angiography; Maculopathy; Paclitaxel

Mesh:

Substances:

Year:  2017        PMID: 29270811     DOI: 10.1007/s10384-017-0552-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  9 in total

1.  Paclitaxel maculopathy.

Authors:  Mandar M Joshi; Bruce R Garretson
Journal:  Arch Ophthalmol       Date:  2007-05

2.  Cystoid macular edema secondary to albumin-bound paclitaxel therapy.

Authors:  Stacy V Smith; Matthew S Benz; David M Brown
Journal:  Arch Ophthalmol       Date:  2008-11

3.  Abraxane-induced cystoid macular edema refractory to concomitant intravenous bevacizumab.

Authors:  Darrell E Baskin; Sunir J Garg
Journal:  Can J Ophthalmol       Date:  2011-04       Impact factor: 1.882

4.  The histopathology of cystoid macular edema.

Authors:  J R Wolter
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

5.  [A case of cystic maculopathy during paclitaxel therapy].

Authors:  Sei Ito; Masatoshi Okuda
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2010-01

6.  The mystery of angiographically silent macular oedema due to taxanes.

Authors:  Tatiana I Kuznetcova; Petr Cech; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2012-04-08       Impact factor: 2.031

7.  Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome.

Authors:  David G Telander; David Sarraf
Journal:  Semin Ophthalmol       Date:  2007 Jul-Sep       Impact factor: 1.975

8.  Cystic maculopathy with normal capillary permeability secondary to docetaxel.

Authors:  Bruce A Teitelbaum; David J Tresley
Journal:  Optom Vis Sci       Date:  2003-04       Impact factor: 1.973

9.  Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment.

Authors:  K A Semb; S Aamdal; P Oian
Journal:  J Clin Oncol       Date:  1998-10       Impact factor: 44.544

  9 in total
  1 in total

Review 1.  Cystoid macular oedema without leakage in fluorescein angiography: a literature review.

Authors:  Masood Naseripour; Sara Hemmati; Samira Chaibakhsh; Arzhang Gordiz; Leila Miri; Fatemeh Abdi
Journal:  Eye (Lond)       Date:  2022-09-10       Impact factor: 4.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.